Modulation of the effect of vascular endothelial growth factor on endothelial cells by heparin: Critical role of nitric oxide-mediated mechanisms

Journal of Nephrology

Volumn 18, Issue 3, 2005, Pages 234-242

  Yagüe, Susana ^a   Alvarez Arroyo, Victoria ^a   Castilla, Angeles ^a   Gonzáles Pacheco, Francisco R ^a   Llamas, Pilar ^a   Caramelo, Carlos ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Endothelial cell; Endothelial nitric oxide synthase; High molecular weight heparin; Low molecular weight heparin; Nitric oxide; Proliferation; Vascular endothelial growth factor

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BEMIPARIN; CALCIUM ION; CHROMIUM 51; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEPARIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; THROMBOPLASTIN; THYMIDINE; TRITIUM; VASCULOTROPIN;

ANIMAL CELL; AORTA; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL PROLIFERATION; CELL PROTECTION; CHROMIUM 51 RELEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; CYTOTOXICITY; DRUG MECHANISM; DRUG SPECIFICITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTICOAGULANTS; AORTA; BLOTTING, NORTHERN; CATTLE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHROMONES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FLOW CYTOMETRY; HEPARIN; MORPHOLINES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 23144464378     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Engelberg H. Actions of heparin in the atherosclerotic process. Pharmacol Rev 1996; 48: 327-52.
2. Giraux JL, Matou S, Bros A, Tapon-Bretaudiere J, Letourneur D, Fischer AM. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin. Eur J Cell Biol 1998; 77: 352-9.
3. Presta M, Leali D, Stabile H, Ronca R, Camozzi M, Coco L, Moroni E, Lickens S, Rusnati M. Heparin derivatives as angiogenesis inhibitors. Curr Pharm Des 2003; 9: 553-66.
4. Norrby K, Ostergaard P. Basic fibroblast growth factor mediated de novo angiogenesis is more effectively suppressed by low molecular weight than by high molecular weight heparin. Int J Microcirc Clin Exp 1996; 16: 8-15.
5. Norrby K, Ostergaard P. A 5.0-kD heparin fraction systemically suppresses VEGF165-mediated angiogenesis. Int J Microcirc Clin Exp 1997; 17: 314-21.
6. Dougher AM, Wasserstrom H, Torley L, Shridaran L, Westdock P, Hileman RE, Fromm JR, Anderberg R, Lyman S, Linhardt RJ, Kaplan J, Terman BI. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor. Growth Factors 1997; 14: 257-68.
7. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface associated heparin like molecules. J Biol Chem 1992; 267: 6093-8.
8. Fairbrother WJ, Champe MA, Christinger HW, Keyt BA, Starovasnik MA. Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure 1998; 6: 637-48.
9. Ferrara N, Gerber HP, Le Couter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-76.
10. Li JM, Hajarizadeh H, La Rosa CA, Rohrer MJ, Vander Salm TJ, Cutler BS. Heparin and protamine stimulate the production of nitric oxide. J Cardiovasc Surg (Torino) 1996; 37: 445-52.
11. Yokokawa K, Tahara H, Kohno M, Mandal AF, Yanagisawa M, Takeda T. Heparin regulates endothelin production through endothelium derived nitric oxide in human endothelial cells. J Clin Invest 1993; 92: 2080-5.
12. Minami M, Yokokawa K, Kohno M, Ikeda M, Horio T, Kano H, Hanehira T, Yasunari K, Takeda T. Promotion of nitric oxide formation by heparin in cultured aortic endothelial cells from spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1995; 2 (suppl 1): S146-7.
13. Upchurch GR Jr, Welch GN, Freedman JE, Fabian AJ, Pigazzi A, Scribner AM, Alpert CS, Keaney JF Jr, Loscalzo J. High dose heparin decreases nitric oxide production by cultured bovine endothelial cells. Circulation 1997; 95: 2115-21.
14. Castilla MA, Neria F, Renedo G, Pereira DS, González-Pacheco FR, Jiménez S, Tramón P, Deudero JJ, Alvarez Arroyo MV, Yagüe S, Caramelo C. Tumor-induced endothelial cell activation: role of vascular endothelial growth factor. Am J Physiol Cell Physiol 2004; 286: C1170-6.
15. Castilla MA, Caramelo C, Gazapo RM, Martin O, Gonzalez-Pacheco FR, Tejedor A, Bragado, R, Arroyo MV. Role of vascular endothelial growth factor (VEGF) in endothelial cell protection against cytotoxic agents. Life Sci 2000; 67: 1003-13.
16. Castilla MA, Alvarez-Arroyo MV, Aceituno E, Aragoncillo P, Gonzalez-Pacheco FR, Texeiro E, Bragado R, Caramelo C. Disruption of cadherin-related junctions triggers autocrine expression of vascular endothelial growth factor in bovine aortic endothelial cells: effects on cell proliferation and death resistance. Circ Res 1999; 85: 1132-8.
17. Goerges AL, Nugent MA. Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem 2003; 278: 19518-25.
18. Castellot JJ Jr, Wong K, Herman B, Hoover RL, Albertini DF, Wright TC, Caleb BL, Karnovsky MJ. Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol 1985; 124: 13-20.
19. Caramelo C, Espinosa G, Manzarbeitia F, Cernadas MR, Perez Tejerizo G, Tan D, Mosquera JR, Digiuni E, Monton M, Millas I, Hernando L, Casado S, Lopez-Farre A. Role of endothelium-related mechanisms in the pathophysiology of renal ischemia/reperfusion in normal rabbits. Circ Res 1996; 79: 1031-8.
20. Alvarez Arroyo MV, Castilla MA, Gonzalez Pacheco FR, Tan D, Riesco A, Casado S, Caramelo C. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation. J Am Soc Nephrol 1998; 9: 1998-2004.
21. Abe K, Shoji M, Chen J, Bierhaus A, Danave I, Micko C, Casper K, Dillehay DL, Nawroth PP, Rickles FR. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci U S A 1999; 96: 8663-8.
22. Caramelo C, Okada K, Tsai P, Schrier RW. Phorbol esters and arginine vasopressin in vascular smooth muscle cell activation. Am J Physiol 1989; 256: F875-81.
23. Dimmeler S, Zeiher AM. Nitric oxide - an endothelial cell survival factor. Cell Death Differ 1999; 6: 964-8.
24. Liu L, Stamler JS. NO: an inhibitor of cell death. Cell Death Differ 1999; 6: 937-42.
25. Polte T, Oberle S, Schroder H. The nitric oxide donor SIN-1 protects endothelial cells from tumor necrosis factor-alpha-mediated cytotoxicity: possible role for cyclic GMP and heme oxygenase. J Mol Cell Cardiol 1997; 29: 3305-10.
26. Shen BQ, Lee DY, Cortopassi KM, Damico LA, Zioncheck TF. Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cell. J Biol Chem 2001; 276: 5281-6.
27. Chung NA, Belgore F, Li-Saw-Hee FL, Conway DS, Blann AD, Lip GY. Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor? Stroke 2002; 33: 2187-91.
28. Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994; 94: 1320-7.
29. Cohen T, Gitay-Goren H, Sharon R, Shibuya M, Halaban R, Levi BZ, Neufeld G. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 1995; 270: 11322-6.
30. Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001; 49: 568-81.
31. Gelinas DS, Bernatchez PN, Rollin S, Bazan NG, Sirois MG. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. Br J Pharmacol 2002; 137: 1021-30.
32. Van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM. Vascular endothelial growth factor/ vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997; 95: 1030-7.